Aybintio
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aybintio, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: EMA Authorised: Aybintio (bevacizumab) — Samsung Bioepis NL B.V.
1 regulatory and trial event tracked for Aybintio, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: EMA Authorised: Aybintio (bevacizumab) — Samsung Bioepis NL B.V.